Cargando…
USA300 Methicillin-Resistant Staphylococcus aureus, United States, 2000–2013
In the United States, methicillin-resistant Staphylococcus aureus (MRSA) with the USA300 pulsed-field gel electrophoresis type causes most community-associated MRSA infections and is an increasingly common cause of health care–associated MRSA infections. USA300 probably emerged during the early 1990...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4622244/ https://www.ncbi.nlm.nih.gov/pubmed/26484389 http://dx.doi.org/10.3201/eid2111.150452 |
_version_ | 1782397565964124160 |
---|---|
author | Carrel, Margaret Perencevich, Eli N. David, Michael Z. |
author_facet | Carrel, Margaret Perencevich, Eli N. David, Michael Z. |
author_sort | Carrel, Margaret |
collection | PubMed |
description | In the United States, methicillin-resistant Staphylococcus aureus (MRSA) with the USA300 pulsed-field gel electrophoresis type causes most community-associated MRSA infections and is an increasingly common cause of health care–associated MRSA infections. USA300 probably emerged during the early 1990s. To assess the spatiotemporal diffusion of USA300 MRSA and USA100 MRSA throughout the United States, we systematically reviewed 354 articles for data on 33,543 isolates, of which 8,092 were classified as USA300 and 2,595 as USA100. Using the biomedical literature as a proxy for USA300 prevalence among genotyped MRSA samples, we found that USA300 was isolated during 2000 in several states, including California, Texas, and midwestern states. The geographic mean center of USA300 MRSA then shifted eastward from 2000 to 2013. Analyzing genotyping studies enabled us to track the emergence of a new, successful MRSA type in space and time across the country. |
format | Online Article Text |
id | pubmed-4622244 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Centers for Disease Control and Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-46222442015-11-02 USA300 Methicillin-Resistant Staphylococcus aureus, United States, 2000–2013 Carrel, Margaret Perencevich, Eli N. David, Michael Z. Emerg Infect Dis Research In the United States, methicillin-resistant Staphylococcus aureus (MRSA) with the USA300 pulsed-field gel electrophoresis type causes most community-associated MRSA infections and is an increasingly common cause of health care–associated MRSA infections. USA300 probably emerged during the early 1990s. To assess the spatiotemporal diffusion of USA300 MRSA and USA100 MRSA throughout the United States, we systematically reviewed 354 articles for data on 33,543 isolates, of which 8,092 were classified as USA300 and 2,595 as USA100. Using the biomedical literature as a proxy for USA300 prevalence among genotyped MRSA samples, we found that USA300 was isolated during 2000 in several states, including California, Texas, and midwestern states. The geographic mean center of USA300 MRSA then shifted eastward from 2000 to 2013. Analyzing genotyping studies enabled us to track the emergence of a new, successful MRSA type in space and time across the country. Centers for Disease Control and Prevention 2015-11 /pmc/articles/PMC4622244/ /pubmed/26484389 http://dx.doi.org/10.3201/eid2111.150452 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited. |
spellingShingle | Research Carrel, Margaret Perencevich, Eli N. David, Michael Z. USA300 Methicillin-Resistant Staphylococcus aureus, United States, 2000–2013 |
title | USA300 Methicillin-Resistant Staphylococcus aureus, United States, 2000–2013 |
title_full | USA300 Methicillin-Resistant Staphylococcus aureus, United States, 2000–2013 |
title_fullStr | USA300 Methicillin-Resistant Staphylococcus aureus, United States, 2000–2013 |
title_full_unstemmed | USA300 Methicillin-Resistant Staphylococcus aureus, United States, 2000–2013 |
title_short | USA300 Methicillin-Resistant Staphylococcus aureus, United States, 2000–2013 |
title_sort | usa300 methicillin-resistant staphylococcus aureus, united states, 2000–2013 |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4622244/ https://www.ncbi.nlm.nih.gov/pubmed/26484389 http://dx.doi.org/10.3201/eid2111.150452 |
work_keys_str_mv | AT carrelmargaret usa300methicillinresistantstaphylococcusaureusunitedstates20002013 AT perencevichelin usa300methicillinresistantstaphylococcusaureusunitedstates20002013 AT davidmichaelz usa300methicillinresistantstaphylococcusaureusunitedstates20002013 |